CD8A and cancer: This is further supported by the finding that cancer cell-intrinsic expression of sCTLA-4 did not provide growth advantage to cancer cells in vitro or in an immunocompromised host, evidence that largely favors the hypothesis that immune cells, particularly CD8+ T cells, are being held at bay by sCTLA-4.